News DMS Imaging

Equities

DMSIM

BE0974289218

Market Closed - Euronext Bruxelles Other stock markets 16:35:13 30/04/2024 BST			5-day change	1st Jan Change
0.024 ^EUR	+33.33%		+15.38%	+2.13%

2023	DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DMS Imaging : Résultats annuels 2023 et chiffre d’affaires du 1er trimestre 2024	04-18	PU
DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2023	21/09/23	CI
Dms Imaging : DMS IMAGING : End of the ongoing procedure with Thierry Legon and reinstatement of the judicial reorganization plan homologated on February 9, 2021.	23/05/23	AT
DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Dms Imaging : Record quarterly revenue: EUR 10.1 million in the 1st quarter of 2023, organic growth +16% - Confirmation of 2023 targets and perspectives	20/04/23	AT
Dms Imaging : 2022 revenue: EUR 35.3 m - 2023 targets and perspectives	20/01/23	AT
Diagnostic Medical Systems Unit Receives Order for Radiology Tables in Italy	12/01/23	MT
Dms Imaging : Fujifilm Healthcare Italy wins tender for 96 X-ray tables, designed and produced by DMS Imaging	12/01/23	AT
Dms Imaging : 2022 bi-annual results	03/10/22	AT
DMS Imaging SA Reports Earnings Results for the Half Year Ended June 30, 2022	30/09/22	CI
DMS Imaging : Annual Financial Report 2021	01/08/22	PU
DMS Imaging SA Reports Earnings Results for the Full Year Ended December 31, 2021	30/04/22	CI
DMS Imaging: Publication Regarding a Transparency Notification	28/02/22	BU
Diagnostic Medical Systems Takes Majority Stake In Asit Biotech	25/01/22	MT
Global markets live: Microsoft, Apple, The Boeing Company, AT&T, Activision Blizzard...	15/09/21
ASIT biotech : 2020 annual financial report	30/04/21	PU
Egg Allergy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight \| Aimmune Therapeutics, DBV Technologies, ASIT Biotechand Others.	16/04/21	AQ
ASIT biotech : presents its 2020 half year results and provides a business update until end 2020	30/09/20	PU
ASIT biotech : 2020 interim financial report as of June 30, 2020	30/09/20	PU
ASIT biotech : Presents Its 2020 Half Year Results and Provides a Business Update Until End 2020	30/09/20	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News DMS Imaging

Equities

DMSIM

BE0974289218

Summary

Filters